Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 1993845)

Published in J Immunol on March 01, 1991

Authors

P J Morrissey1, P Conlon, S Braddy, D E Williams, A E Namen, D Y Mochizuki

Author Affiliations

1: Immunex Corporation, Seattle, WA 98101.

Articles by these authors

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med (1994) 8.97

Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77

Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature (1988) 5.50

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med (1993) 4.64

Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med (1995) 4.34

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell (1990) 4.15

Identification of a ligand for the c-kit proto-oncogene. Cell (1990) 4.04

Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med (1993) 3.38

Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell (1990) 2.95

A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol (1994) 2.87

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science (1986) 2.84

Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines. J Exp Med (1986) 2.71

Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol (1989) 2.64

B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med (1988) 2.64

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat Med (2000) 2.62

Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci U S A (1989) 2.46

Retained asymptomatic third molars and risk for second molar pathology. J Dent Res (2013) 2.43

Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science (1992) 2.40

Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J Exp Med (1990) 2.37

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30

Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest (1994) 2.29

Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med (2000) 2.21

Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol (1989) 2.11

Hematologic effects of flt3 ligand in vivo in mice. Blood (1996) 2.02

Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med (1999) 1.91

Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc (1984) 1.89

Murine thymocytes proliferate in direct response to interleukin-7. Blood (1989) 1.86

The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol (1986) 1.85

A test of crystal structure prediction of small organic molecules. Acta Crystallogr B (2000) 1.84

Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol (1996) 1.82

Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 1.80

The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor. Mol Cell Biol (1991) 1.76

Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J Immunol (1996) 1.76

Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc (2000) 1.74

Human interleukin 1. Purification to homogeneity. J Exp Med (1985) 1.72

Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J Biol Chem (1986) 1.71

Medical and economic costs of psychologic distress in patients with coronary artery disease. Mayo Clin Proc (1995) 1.70

Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature (1991) 1.67

Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A (1991) 1.66

Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci U S A (1987) 1.65

Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab (1975) 1.64

Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1985) 1.62

Regulation of human T cell proliferation by IL-7. J Immunol (1990) 1.58

Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J (1991) 1.58

Molecular characterization of interleukin 2. Immunol Rev (1982) 1.52

Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med (1993) 1.52

Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol (1998) 1.51

c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell (1992) 1.50

Regulation of T cell proliferation by IL-7. J Immunol (1990) 1.50

Long-term psychologic implications of congenital heart disease: a 25-year follow-up. Mayo Clin Proc (1991) 1.49

Fish models for environmental carcinogenesis: the rainbow trout. Environ Health Perspect (1996) 1.48

Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia. Proc Natl Acad Sci U S A (1984) 1.47

Chemical and biological evidence links microcystins to salmon 'netpen liver disease'. Toxicon (1993) 1.46

A prospective psychological evaluation of patients with dysphagia of various etiologies. Dysphagia (1996) 1.44

Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg (1984) 1.41

Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. J Immunol (1991) 1.40

Inducible production of human macrophage growth factor, CSF-1. Blood (1986) 1.40

Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood (1994) 1.37

Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J (1991) 1.37

Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood (1991) 1.35

Echocardiographic detection of large left to right shunts and cardiomyopathies in infants and children. Am J Cardiol (1976) 1.34

Human IL-7: a novel T cell growth factor. J Immunol (1989) 1.34

Pulmonary function studies in healthy Pakistani adults. Thorax (1978) 1.34

Self-injurious behavior: a state-wide prevalence survey of the extent and circumstances. Appl Res Ment Retard (1986) 1.34

Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J Immunol (1991) 1.32

The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med (1991) 1.32

A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis (1999) 1.31

Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect (2001) 1.31

Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol (2007) 1.29

IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol (1994) 1.29

Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine. J Biol Chem (2001) 1.27

The production of myeloid blood cells and their regulation during health and disease. Crit Rev Oncol Hematol (1988) 1.26

Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg (1981) 1.25

A device for recording automatic audio tape recording. J Appl Behav Anal (1971) 1.24

Bactericidal properties of a new water disinfectant. Appl Environ Microbiol (1985) 1.23

The Steel factor. Dev Biol (1992) 1.23

Regulation of apoptosis and T cell activation by Fas-specific mAb. Int Immunol (1994) 1.22

Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22

Interleukin 7 is produced by murine and human keratinocytes. J Exp Med (1993) 1.22

Utilizing increased response effort to reduce chronic hand mouthing. J Appl Behav Anal (1998) 1.22

Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate (2001) 1.21

Syntheses and antibacterial activity of new N-halamine compounds. J Pharm Sci (1987) 1.20

Interleukin 1 plus interleukin 3 plus colony-stimulating factor 1 are essential for clonal proliferation of primitive myeloid bone marrow cells. Exp Hematol (1989) 1.19

Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplasmic tail. Genes Dev (1992) 1.19

Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J Immunol (1998) 1.16

Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest (1987) 1.14

Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J Neurochem (2002) 1.13

Clinical evaluation of the self-injurious behavior inhibiting system (SIBIS). J Appl Behav Anal (1990) 1.13

Mycobacterium avium-intracellulare complex: evaluation with CT. Radiology (1993) 1.13

Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc (1983) 1.12

Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. J Clin Endocrinol Metab (1976) 1.12

Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24. Cell Growth Differ (1991) 1.12

Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis (1998) 1.11

Sleep disturbances in patients with mild-stage Alzheimer's disease. J Gerontol (1990) 1.10

Inactivation of Legionella pneumophila by hypochlorite and an organic chloramine. Appl Environ Microbiol (1987) 1.09

The influence of age on the electroretinogram and visual evoked potential. Doc Ophthalmol (1985) 1.08

Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its C-terminal, cytoplasmic domain. J Biol Chem (1986) 1.07